1. Home
  2. UBX vs ONMD Comparison

UBX vs ONMD Comparison

Compare UBX & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • ONMD
  • Stock Information
  • Founded
  • UBX 2009
  • ONMD 2006
  • Country
  • UBX United States
  • ONMD United States
  • Employees
  • UBX N/A
  • ONMD N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • ONMD
  • Sector
  • UBX Health Care
  • ONMD
  • Exchange
  • UBX Nasdaq
  • ONMD Nasdaq
  • Market Cap
  • UBX 36.9M
  • ONMD 32.5M
  • IPO Year
  • UBX 2018
  • ONMD N/A
  • Fundamental
  • Price
  • UBX $1.72
  • ONMD $0.72
  • Analyst Decision
  • UBX Strong Buy
  • ONMD
  • Analyst Count
  • UBX 3
  • ONMD 0
  • Target Price
  • UBX $7.33
  • ONMD N/A
  • AVG Volume (30 Days)
  • UBX 129.4K
  • ONMD 50.3K
  • Earning Date
  • UBX 03-07-2025
  • ONMD 12-17-2024
  • Dividend Yield
  • UBX N/A
  • ONMD N/A
  • EPS Growth
  • UBX N/A
  • ONMD N/A
  • EPS
  • UBX N/A
  • ONMD 0.01
  • Revenue
  • UBX N/A
  • ONMD $957,651.00
  • Revenue This Year
  • UBX N/A
  • ONMD N/A
  • Revenue Next Year
  • UBX N/A
  • ONMD N/A
  • P/E Ratio
  • UBX N/A
  • ONMD $86.28
  • Revenue Growth
  • UBX N/A
  • ONMD 1.36
  • 52 Week Low
  • UBX $0.94
  • ONMD $0.46
  • 52 Week High
  • UBX $3.10
  • ONMD $3.37
  • Technical
  • Relative Strength Index (RSI)
  • UBX 46.69
  • ONMD 34.32
  • Support Level
  • UBX $1.53
  • ONMD $0.57
  • Resistance Level
  • UBX $1.76
  • ONMD $0.77
  • Average True Range (ATR)
  • UBX 0.20
  • ONMD 0.09
  • MACD
  • UBX -0.02
  • ONMD -0.02
  • Stochastic Oscillator
  • UBX 34.99
  • ONMD 30.63

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real-World Data or iRWDTM. OneMedNet's innovative solutions connect healthcare providers and patients satisfying a crucial need within the Life Sciences field offering direct access to clinical images and the associated contextual patient record.

Share on Social Networks: